Liraglutide for Obesity
Study Summary
This trial is testing whether liraglutide helps children with obesity lose weight. Children will be randomly assigned to receive either liraglutide or a placebo, and researchers will track how much weight the children lose and if there are any side effects.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2017 Phase 4 trial • 100 Patients • NCT02014740Awards & Highlights
Trial Design
Find a site
Who is running the clinical trial?
Media Library
Frequently Asked Questions
How many people total will be participating in this research project?
"Obesity clinical trials are currently recruiting 998 participants while Liraglutide clinical trials are actively enrolling 36 patients. This particular study, however, is not presently looking for volunteers. The trial was initially posted on 3/4/2021 and last updated on 11/10/2022."
Could you explain the risks associated with taking Liraglutide?
"Liraglutide is considered safe, as it has received a score of 3. This is due to the fact that this medication has entered Phase 3 clinical trials, meaning there is significant data supporting its efficacy and safety."
What are some of the main conditions that Liraglutide has been known to improve?
"Patients that commonly use liraglutide do so as part of an exercise regime. However, this medication can also help those who have unsuccessfully tried monotherapy and those suffering from cardiovascular disease or risks thereof."
Are there any available appointments for this research program?
"The latest information available on clinicaltrials.gov indicates that this study is not recruiting patients at the moment. The listing was first posted on March 4th, 2021 and updated November 10th, 2022. While subjects are not being recruited for this trial, there are 1,034 other studies currently looking for volunteers."
How can I join this clinical trial?
"The current recruitment goal for this clinical trial is 78 children, aged 6 to 12 years old, that suffer from obesity. To qualify, patients must meet the following body mass index criteria: their BMI must be equal to or greater than the 95th percentile when compared against gender and age-specific growth charts (CDC.gov)."
Are there other examples of drugs similar to Liraglutide that have been trialed?
"UBMD Pediatrics, Division of Pediatric Endocrinology first studied liraglutide in 2012. Since then, a total of 18519 completed studies have been conducted worldwide. There are currently 36 clinical trials recruiting patients actively, with many of these taking place in Dayton, Ohio."
How many staff members are managing this clinical trial today?
"Patients are encouraged to select the clinical trial site nearest them to minimize travel as this study is being conducted at 7 different locations. The sites are situated in cities including Dayton, Pittsburgh and Baton Rouge among others."
Are elderly patients within the age limit for this experiment?
"The pool of potential participants for this clinical trial must, at a minimum, be 6 years old but not older than 12."